Michael Geraghty

This profile gathers the share dealings of Michael Geraghty in Apyx Medical Corp, where the filings describe the role as board member. Between 11 May 2022 and 6 June 2023, the trades on record add up to 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 9 June 2023, reports an option exercise of €26k in Apyx Medical Corp. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.